These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2890254)

  • 1. [Sensorimotor polyneuropathy induced by almitrine dimesylate. Anatomo-clinical study of a case].
    Rousseau JJ; Lust CA; Brucher JM
    Acta Neurol Belg; 1987; 87(4):197-206. PubMed ID: 2890254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuropathies and almitrine. 14 cases].
    Petit H; Leys D; Hurtevent JF; Parent M; Caron J; Salomez JL; Krivosic I
    Rev Neurol (Paris); 1987; 143(6-7):510-9. PubMed ID: 2889253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy in patients treated with almitrine dimesylate.
    Gherardi R; Louarn F; Benvenuti C; Perrier M; Lejonc JL; Schaeffer A; Degos JD
    Lancet; 1985 Jun; 1(8440):1247-50. PubMed ID: 2860446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
    Voisin C; Howard P; Ansquer JC
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Almitrine bismesylate. A peripheral chemoreceptor agonist].
    Nielsen SP
    Ugeskr Laeger; 1988 Nov; 150(46):2797-800. PubMed ID: 2905090
    [No Abstract]   [Full Text] [Related]  

  • 6. [11 cases of neuropathy induced by almitrine, of which one had optic neuropathy].
    Blondel M; Arnott G; Defoort S; Bouchez B; Persuy P; Masingue M; Hache JC; Krivosic I
    Rev Neurol (Paris); 1986; 142(8-9):683-8. PubMed ID: 2880378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral axonic neuropathy during treatment with almitrine bismesylate (Vectarion). Possible role of wasting].
    Gherardi R; Louarn F; Perrier M; Eizenbaum JF
    J Toxicol Clin Exp; 1985; 5(6):393-7. PubMed ID: 2878072
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of peripheral nerve function in hypoxaemic COPD patients taking almitrine bismesylate: a prospective long-term study.
    Lerebours G; Senant J; Moore N; Arnaud F; David P; Ozenne G; Nouvet G
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():203s-206s. PubMed ID: 2825867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients.
    Sadoul P
    Eur J Respir Dis Suppl; 1983; 126():357-61. PubMed ID: 6373344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
    Ansquer JC; Bertrand A; Blaive B; Charpin J; Chrétien J; Decroix G; Kalb JC; Lissac J; Michel FB; Morère P
    Rev Mal Respir; 1985; 2 Suppl 1():S61-7. PubMed ID: 2870549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
    Ansquer JC
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peripheral neuropathy in chronic bronchopathy. A study of 128 patients].
    Lerebours G; Nouvet G; Senant J; Moore N; Arnaud F
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():400-2. PubMed ID: 2902611
    [No Abstract]   [Full Text] [Related]  

  • 13. Almitrine as a long term treatment for chronic obstructive pulmonary disease.
    Kauffmann F
    Bull Eur Physiopathol Respir; 1987; 23(6):667. PubMed ID: 2899444
    [No Abstract]   [Full Text] [Related]  

  • 14. Long term studies on almitrine bismesylate in COPD patients.
    Bourgouin-Karaouni D; Mercier J; Prefaut C
    Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology].
    Mihalţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):209-19. PubMed ID: 2894713
    [No Abstract]   [Full Text] [Related]  

  • 16. Ten cases of peripheral neuropathy during treatment with almitrine in COPD patients.
    Gerard M; Leger P; Couturier JC; Robert D
    Eur J Respir Dis Suppl; 1986; 146():591-6. PubMed ID: 3023128
    [No Abstract]   [Full Text] [Related]  

  • 17. [Microfluorimetric study of the effect of almitrine bismesylate (Vectarion) on intrapulmonary neuroepithelial bodies].
    Lauweryns JM; van Lommel A; van Meerbeek J
    Rev Mal Respir; 1985; 2 Suppl 1():S35-7. PubMed ID: 2870545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should arterial gas values be improved in patients with chronic bronchitic respiratory insufficiency? Value of almitrine dimesylate].
    Prefaut C
    Presse Med; 1984 Oct; 13(34):2090-3. PubMed ID: 6149537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Almitrine and peripheral neuropathy.
    Suggett AJ; Jarratt JA; Proctor A; Howard P
    Lancet; 1985 Oct; 2(8459):830-1. PubMed ID: 2864548
    [No Abstract]   [Full Text] [Related]  

  • 20. Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease.
    Stradling JR; Nicholl CG; Cover D; Davies EE; Hughes JM; Pride NB
    Eur J Respir Dis Suppl; 1983; 126():255-64. PubMed ID: 6373340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.